If I'm not mistaken, the US authorities require phase 3 trials of AT LEAST 30,000 people before they will approve any vaccine. It's the same in other democratic countries. But not in the kind of country where any opposition leaders get poisoned with or gunned down.Daleinpattaya wrote: ↑Sat Oct 24, 2020 10:29 amBy sheer chance, thousands of vaccinated people will have heart attacks, strokes and other illnesses shortly after being injected. Determining if those ailments were triggered by a vaccine will require a sophisticated, highly coordinated effort by federal and state agencies, hospitals and drug makers. And any issues or problems that arise will need to be clearly communicated to a distrustful public that is awash in disinformation.
Obviously these trials involve comparing the results of people with the placebo group and the ones with the vaccine, typically at least 15,000 in each group. So if there are any significant abnormalities in response, death rate or whatever, it should be obvious with this kind of sample size.
Now, without any covid restrictions, perhaps 60~70% of the population might get covid and perhaps 1% of them may die.
15000 x 60% x 1% = 90 covid deaths.
I'm fairly sure if the 15000 vaccine group has 90 more deaths than the placebo group, this would be detected during the trial. Since Donald Trump does not control the process, we can rely on results being reported. When trials and approvals occur in several countries, the risk is further reduced.
We also have to remember, that the covid mortality rate for board members would be higher, due to age. So taking the vaccine is an easy decision.
Of course, there will be tribes of anti-vaccers spreading disinformation, as implied by the New York Times. I shall ignore them and just do the maths.